Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-6-8
|
pubmed:abstractText |
Human immunodeficiency virus type 1 (HIV-1) has tropism for helper T lymphocytes and cells of the monocyte/ macrophage lineages. HIV-1 can also infect other cell types, including B cells. We show here that 10% of fresh circulating B cells from HIV-1-seronegative donors (i) express the CD4 receptor and CCR5 and CXCR4, two recently described coreceptors for HIV-1 and (ii) are permissive to HIV-1 with de novo proviral DNA integration following ex vivo infection by either SI (syncytium-inducing) or NSI (non-syncytium-inducing) isolates. To get further information on the interaction between HIV and B cells, the susceptibility of several EBV-positive or -negative B cell lines to infection by SI and NSI isolates was checked. Following infection of an EBV- CD4+ CXCR4+ CCR5- B cell line (DG75) by an SI HIV-1 isolate, we obtained a cell line which chronically produced low-level infectious HIV-1 for 2 years (HIV-DG75). Immunocytochemical data, combined with in situ PCR data, established that HIV-DG75 cells consist of at least three populations uninfected cells, infected virus-producing cells, and infected but nonproducing cells. Moreover, HIV-DG75 cells which express p24 antigen do not go into apoptosis, contrary to T lymphocytes. We infer from these results that B cells could constitute a reservoir of infectious virus in infected patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD19,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR5,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CXCR4
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0042-6822
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
244
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
542-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9601522-Antigens, CD19,
pubmed-meshheading:9601522-Antigens, CD4,
pubmed-meshheading:9601522-Apoptosis,
pubmed-meshheading:9601522-B-Lymphocytes,
pubmed-meshheading:9601522-Base Sequence,
pubmed-meshheading:9601522-Cell Line,
pubmed-meshheading:9601522-DNA, Viral,
pubmed-meshheading:9601522-DNA Primers,
pubmed-meshheading:9601522-Gene Expression,
pubmed-meshheading:9601522-Genome, Viral,
pubmed-meshheading:9601522-HIV-1,
pubmed-meshheading:9601522-Herpesvirus 4, Human,
pubmed-meshheading:9601522-Humans,
pubmed-meshheading:9601522-Polymerase Chain Reaction,
pubmed-meshheading:9601522-Receptors, CCR5,
pubmed-meshheading:9601522-Receptors, CXCR4,
pubmed-meshheading:9601522-Virus Replication
|
pubmed:year |
1998
|
pubmed:articleTitle |
Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection.
|
pubmed:affiliation |
Laboratoire de Microbiologie, Hôpital Rothschild, Paris, France.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|